purine has been researched along with Triple Negative Breast Neoplasms in 1 studies
1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH | 1 |
| Bijian, K | 1 |
| Wernic, D | 1 |
| Su, J | 1 |
| da Silva, SD | 1 |
| Yu, H | 1 |
| Qiu, D | 1 |
| Asslan, M | 1 |
| Alaoui-Jamali, MA | 1 |
1 other study available for purine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Autophagy; Cell Line, Tumor; Cell Prolif | 2019 |